Sustained Release Lidocaine for Treatment of Scrotal Pain
Status:
Completed
Trial end date:
2021-03-24
Target enrollment:
Participant gender:
Summary
In this study, the investigators are testing a new formulation of lidocaine for its
suitability in managing chronic scrotal pain (CSCP). The new formulation ST-CP is a lidocaine
sustained-release formulation and is expected to provide pain relief over 4 weeks. Currently,
the drug lidocaine is not available as an injectable slow-release formulation and chronic
scrotal pain patients are often left untreated.